Current Oncology Reports

, Volume 11, Issue 6, pp 482–489 | Cite as

Colorectal cancer screening



Colorectal cancer (CRC) constitutes the second leading cause of death from cancer in the United States. Increased screening for CRC have been associated with a decreased incidence in the past two decades. Continued efforts are necessary to maintain this trend. Appropriate risk stratification of individuals and compliance with recommended screening strategies are important. Colonoscopy continues to play an important role in screening; however, several different screening options are available for average-risk individuals. This article reviews the current options open to physicians to adequately screen patients for CRC based on inherit risks.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Jemal A, Siegal R, Ward E, et al.: Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71–96.CrossRefPubMedGoogle Scholar
  2. 2.
    Jemal A, Thun MJ, Ries LA, et al.: Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008, 100:1672–1694.CrossRefPubMedGoogle Scholar
  3. 3.
    SEER Cancer Statistics Review, 1975–2004. Edited by Ries L, Melbert D, Krapcho M, et al.: Bethesda, MD: National Cancer Institute; 2007.Google Scholar
  4. 4.
    Winawer SE, Zauber AG, Stewart E, O’Brien MJ: The natural history of colorectal cancer. Opportunities for intervention. Cancer 1991, 67:1143–1149.CrossRefPubMedGoogle Scholar
  5. 5.
    O’Brien MJ, Winawer SJ, Zauber AG, et al.: The National Polyps Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990, 98:371–379.PubMedGoogle Scholar
  6. 6.
    Bond JH: Colon polyps and cancer. Endoscopy 2003, 35:27–35.CrossRefPubMedGoogle Scholar
  7. 7.
    Winawer SJ, Fletcher RH, Miller L, et al.: Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997, 112:594–642.CrossRefPubMedGoogle Scholar
  8. 8.
    Winawer SJ: Natural history of colorectal cancer. Am J Med 1999, 106:3S–6S.CrossRefPubMedGoogle Scholar
  9. 9.
    Seff LC, Nadel MR, Klabunde CN, Thompson T, et al.: Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer 2004, 100:2093–2103.CrossRefGoogle Scholar
  10. 10.
    Allison JE, Tekawa IS, Ransom LJ, et al.: A comparison of fecal occult-blood tests for colorectal cancer screening. N Engl J Med 1996, 334:155–159.CrossRefPubMedGoogle Scholar
  11. 11.
    Ransohoff DF, Lang CA: Screening for colorectal cancer with the fecal occult blood test, a background paper. American College of Physicians. Ann Intern Med 1997, 126:811–822.PubMedGoogle Scholar
  12. 12.
    Hardcastle JD, Chamberlain JO, Robinson MH, et al.: Randomized controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996, 348:1472–1477.CrossRefPubMedGoogle Scholar
  13. 13.
    Kronborg O, Fenger C, Olsen J, et al.: Randomized study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996, 348:1467–1471.CrossRefPubMedGoogle Scholar
  14. 14.
    Wilson JG, Junger G: Principals and Practice of Screening for Disease. Geneva, Switzerland: World Health Organization; 1968.Google Scholar
  15. 15.
    Levi Z, Rozen P, Hazazi R, et al.: A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007, 146:244–245.PubMedGoogle Scholar
  16. 16.
    Allison JE, Sakoda LC, Levin TR, et al.: Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007, 99:1462–1470.CrossRefPubMedGoogle Scholar
  17. 17.
    Gopalswamy N, Stelling HP, Markert RJ, et al.: A comparative study of eight fecal occult blood tests and HemoQuant in patients in whom colonoscopy is indicated. Arch Fam Med 1994, 3:1043–1048.CrossRefPubMedGoogle Scholar
  18. 18.
    Wong BC, Wong WM, Cheung KL, et al.: A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population. Aliment Pharmacol Ther 2003, 18:941–946.CrossRefPubMedGoogle Scholar
  19. 19.
    Smith A, Young GP, Cole SR, et al.: Comparison of a crushsampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 2006, 107:2151–2159.Google Scholar
  20. 20.
    Kutzner N, Hoffmann I, Kinke C, et al.: Non-invasive detection of colorectal tumors by the combined application of molecular diagnosis and the faecal occult blood test. Cancer Lett 2005, 229:33–41.CrossRefPubMedGoogle Scholar
  21. 21.
    Levin B, Lieberman DA, McFarland B, et al.: Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force of Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008, 58:130–160.CrossRefPubMedGoogle Scholar
  22. 22.
    Selby JV, Friedman GD, Quesenberry CP, et al.: A case control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992, 326:653–657.PubMedGoogle Scholar
  23. 23.
    Newcomb PA, Norgleet RG, Storer BE, et al.: Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992, 84:1572–1575.CrossRefPubMedGoogle Scholar
  24. 24.
    Winawer SJ, Fletcher RH, Miller L, et al.: Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997, 112:594–642.CrossRefPubMedGoogle Scholar
  25. 25.
    Byers T, Levin B, Rothenberger D, et al.: American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA Cancer J Clin 1997, 47:154–160.CrossRefPubMedGoogle Scholar
  26. 26.
    Winawer S, Fletcher R, Rex D, et al.: Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003, 124:544–560.CrossRefPubMedGoogle Scholar
  27. 27.
    Kelvin FM, Gardiner R, Vas W, et al.: Barium enema and endoscopy for the detection of colorectal neoplasia: sensitivity, specificity, complications, and its determinants. Clin Radiol 2001, 56:401–409.CrossRefGoogle Scholar
  28. 28.
    Thorpe CD, Grayson DJ, Wingfield PB: Detection of carcinoma of the colon and rectum by air contrast enema. Surg Gynecol Obstet 1981, 152:307–309.PubMedGoogle Scholar
  29. 29.
    Fork FT, Lindstrom C, Ekelund G: Double contrast examination in carcinoma of the colon and rectum. A prospective clinical series. Acta Radiol Diagn (Stockh) 1983, 24:177–188.Google Scholar
  30. 30.
    Johnson CD, Carlson HC, Taylor WF, et al.: Barium enemas of carcinoma of the colon: sensitivity of double- and single-contrast studies. AJR Am J Roentgenol 1983, 140:1143–1149.PubMedGoogle Scholar
  31. 31.
    Winawer SJ, Steart ET, Zauber AG, et al.: A comparison of colonoscopy and double contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med 2000, 342:1766–1772.CrossRefPubMedGoogle Scholar
  32. 32.
    Farrar WD, Sawhney MS, Nelson DB, et al.: Colorectal cancers found after a complete colonoscopy. Clin Gastroenterol Hpatol 2006, 4:1259–1264.CrossRefGoogle Scholar
  33. 33.
    Pickhardt PG, Nugent PA, Mysliwiec PA, et al.: Location of adenomas missed by optical colonoscopy. Ann Intern Med 2004, 141:352–359.PubMedGoogle Scholar
  34. 34.
    Seeff LC, Richards TB, Shapiro JA, et al.: How many endoscopies are performed for colorectal cancer screening? Results from CDC’s survey of endoscopic capacity. Gastroenterology 2004, 127:1670–1677.CrossRefPubMedGoogle Scholar
  35. 35.
    Winawer SJ, Zuaber AG, Ho MN, et al.: Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993, 329:1977–1981.CrossRefPubMedGoogle Scholar
  36. 36.
    Thiis-Evensen E, Hoff GS, Sauar J, et al.: Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol 1999, 34:414–420.CrossRefPubMedGoogle Scholar
  37. 37.
    Muller AD, Sonnenberg A: Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 1995, 123:904–910.PubMedGoogle Scholar
  38. 38.
    Rex DK, Cutler CS, Lemmel GT, et al.: Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997, 112:24–28.CrossRefPubMedGoogle Scholar
  39. 39.
    Bresslet B, Paszat LF, Vinden C, et al.: Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst 2003, 95:230–236.Google Scholar
  40. 40.
    Gatto NM, Frucht H, Sundararajan V, et al.: Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst 2003, 95:230–236.PubMedCrossRefGoogle Scholar
  41. 41.
    Winawer SJ, Zauber AG, Fletcher RH, et al.: Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin 2006, 56:143–159.CrossRefPubMedGoogle Scholar
  42. 42.
    Winawer SJ, Zauber AG, Gerdes H, et al.: Risk of colorectal cancer in the families of patients with adenomatous polyps. N Engl J Med 1996, 334:82–87.CrossRefPubMedGoogle Scholar
  43. 43.
    Burt RQ, Barthel JS, David DS, et al.: National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology; Colorectal Cancer Screening. Version 2, 2008.Google Scholar
  44. 44.
    Zauber AG, Landsdorp-Vogelaar I, Knudsen AB, et al.: Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2008, 149:659–669.PubMedGoogle Scholar
  45. 45.
    Surveillance Epidemiology and End Results: SEER Cancer Statistics Review, 1975–2000. Edited by Rise LAG, Eisner MP, Kosary CL, et al. Bethesda, MD: National Cancer Institute. Available at Accessed August 2009.
  46. 46.
    Nelson RL, Persky V, Turyk M: Carcinoma in of the colorectum: SEER trends by race, gender, and total colorectal cancer. J Surg Oncol 1999, 71:123–129.CrossRefPubMedGoogle Scholar
  47. 47.
    Agrawal S, Bhypinderjit A, Bhutani MS, et al.: Colorectal cancer in African Americans. Am J Gastroenterol 2005, 100:515–523.CrossRefPubMedGoogle Scholar
  48. 48.
    Klabunde CN, Frame PS, Meadow A, et al.: A national survey of primary care physicians’ colorectal screening recommendations and practices. Prev Med 2003, 36:352–362.CrossRefPubMedGoogle Scholar
  49. 49.
    Meissner HI, Breen N, Klabunde CN, et al.: Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 2006, 15:389–394.CrossRefPubMedGoogle Scholar
  50. 50.
    Breen N, Wagener DK, Brown ML, et al.: Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 2001, 93:1704–1713.CrossRefPubMedGoogle Scholar
  51. 51.
    . Centers for Disease Control and Prevention (CDC): Use of colorectal cancer tests—United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep, 2008:57:253–258.Google Scholar

Copyright information

© Current Medicine Group, LLC 2009

Authors and Affiliations

  1. 1.Section of Colon and Rectal SurgeryCreighton University School of MedicineOmahaUSA

Personalised recommendations